04 October 2017
Switzerland
Reporter: Jenna Lomax

MPP signs HIV drug deal with Gilead


The UN-backed Medicines Patent Pool (MPP) has signed a new generic manufacturing licence with Gilead Sciences for HIV treatments in Europe and the US.

The licence allows manufacturers to develop and sell generic medicines containing bictegravir, if it is approved in the United States.

Gilead Sciences and the MPP are also expanding the geographical scope of licences on other HIV products, enabling generic medicines to be supplied to additional countries such as Belarus, the Philippines, Malaysia and Ukraine.

The new licences are aimed at providing low- and middle-income countries “improved, simplified treatment options, crucial for people living in resource-limited settings," said Greg Perry, executive director of the MPP.

Lelio Marmora, executive director of Unitaid, MPP's funder, said: “We're tremendously pleased with the MPP and Gilead's collaborative efforts over the many years to improve health outcomes in low- and middle-income countries.”

"Through their joint HIV licensing programme, millions stand to benefit from quality-assured generics of new optimised treatment regimens."

Gregg Alton, executive vice president for corporate and medical affairs at Gilead Sciences, added: “These agreements allow for our licensees to provide generic versions of our latest therapies to people living with HIV in the developing world.”

He added: “Today, more than 10 million people in resource-limited countries are on Gilead-based HIV therapies, which would not be possible without these strong alliances.”

More news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
Businesses should prepare for UPC, despite uncertainty
17 October 2017 | London | Reporter: Barney Dixon
Businesses should make preparations for the Unified Patent Court and unitary patent, despite mounting uncertainty surrounding when, if at all, the court will come into effect
Patent ‘irrationality’ causes a negative image of patents
16 October 2017 | London | Reporter: Barney Dixon
Spectators are far more accepting of copyright and trademarks than they are of patents because of “irrationality”, according to Sir Robin Jacob
Partner promotions at White & Case
13 October 2017 | New York | Reporter: Barney Dixon
White & Case has promoted 31 new partners, including four intellectual property attorneys, across the US and UK
Qualcomm hit with $775 million fine in Taiwan
13 October 2017 | Taipei | Reporter: Barney Dixon
Qualcomm has been hit with a $775 million fine, after the Taiwan Fair Trade Commission found that the chipmaker had abused its position in the baseband chip market
SUEPO willing to work with new EPO president
12 October 2017 | Munich | Reporter: Barney Dixon
A source close to the Staff Union of the European Patent Office has revealed it is always willing to work with whoever is elected to lead the European Patent Office
BPTO and EPO sign PPH cooperation treaty
12 October 2017 | São Paulo | Reporter: Barney Dixon
The Brazilian Patent and Trademark Office and the European Patent Office have signed a cooperation treaty, aimed at the creation of a patent prosecution highway between the two offices
Johnson Controls-Hitachi selects Anaqua
11 October 2017 | Boston | Reporter: Barney Dixon
The joint venture between Johnson Controls and Hitachi Air Conditioning has chosen intellectual property analytics company Anaqua to globalise its IP management systems